Blood pressure prior to percutaneous coronary intervention is associated with the risk of end-stage renal disease: a nationwide population based-cohort study
Eun Hui Bae, Sang Yup Lim, Bongseong Kim, Kyung-Do Han, Tae Ryom Oh, Hong Sang Choi, Chang Seong Kim, Seong Kwon Ma, Soo Wan Kim
Kidney Res Clin Pract. 2021;40(3):432-444. Published online 2021 Jul 2 DOI: https://doi.org/10.23876/j.krcp.21.245
|
Citations to this article as recorded by
Fenofibrate and risk of end‐stage renal disease: A nationwide cohort study
Young Youl Hyun, Kyung‐Soo Kim, Sangmo Hong, Kyungdo Han, Cheol‐Young Park
Diabetes, Obesity and Metabolism.2024;[Epub] CrossRef Obesity-related hypertension and chronic kidney disease: from evaluation to management
Mi-Hyang Jung, Sang-Hyun Ihm
Kidney Research and Clinical Practice.2023; 42(4): 431. CrossRef
|